Yuliya Sytnikova
About Yuliya Sytnikova
Yuliya Sytnikova is a Scientist II at LifeMine Therapeutics, specializing in R&D, transcriptomics, and epigenetics. She has extensive experience in studying gene regulatory networks, particularly in relation to cell differentiation and cancer progression.
Current Role at LifeMine Therapeutics
Yuliya Sytnikova serves as Scientist II at LifeMine Therapeutics, a position she has held since 2020. Located in Cambridge, Massachusetts, she engages in research and development activities focusing on transcriptomics and epigenetics. Her work involves studying the regulatory mechanisms that govern gene expression, particularly in relation to therapeutic applications.
Previous Experience in Research
Prior to her current role, Yuliya Sytnikova accumulated extensive research experience. She worked as a Research Fellow at Harvard Medical School and Brigham and Women's Hospital from 2015 to 2020. Additionally, she served as a Research Affiliate at the Broad Institute of MIT and Harvard from 2017 to 2020, where she contributed to various projects in the field of molecular biology.
Education and Academic Background
Yuliya Sytnikova completed her Ph.D. in Biochemistry and Molecular Biology at Ruprecht-Karls-Universität Heidelberg, studying from 2005 to 2011. She also holds a Bachelor of Science and a Master of Science in Biology and Biochemistry from Odessa National 'I.I. Mechnikov' University, where she studied from 1999 to 2004. Her foundational education includes secondary schooling in Chemistry and Biology at Richelieu Lyceum from 1995 to 1999.
Research Focus and Expertise
Yuliya Sytnikova specializes in the study of regulatory networks of genes that influence cell differentiation and cancer progression. Her research employs a combination of biochemical and computational methods to investigate genome activity regulation. She focuses on the roles of transcription factors, chromatin structure, and noncoding RNAs in gene regulation.
Early Career Development
Yuliya Sytnikova began her academic journey as an Undergraduate Student at Odessa National University from 1999 to 2002. She later joined DKFZ, the German Cancer Research Center, as a Graduate Student in Christof Niehrs' lab from 2005 to 2011, where she developed her skills in molecular biology and genomics.